Search
Library
Log in
Watch fullscreen
9 months ago

AstraZeneca's antibody therapy prevents COVID-19

Best Oddly Satisfying
Best Oddly Satisfying
AstraZeneca's new antibody therapy reduced the risk of people developing COVID-19 symptoms by 77% in a late-stage trial, putting the drugmaker on track to offer protection to those who respond poorly to vaccines

#News #Reuters #AstraZeneca #AntibodyTherapy #Vaccines #COVID
See more about

Browse more videos

Browse more videos